AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34245918 — intervention group
Group type: EXPERIMENTAL
Intervention: Active stimulation
Number of subjects: 8
Study 34245918 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 8
Study 35570397 — intervention group
Group type: EXPERIMENTAL
Intervention: 1565-nm non-ablative fractional laser (NAFL)
Number of subjects: 64
Study 35570397 — intervention group
Group type: EXPERIMENTAL
Intervention: topical β-glucan
Number of subjects: 64
Study 35570397 — intervention group
Group type: EXPERIMENTAL
Intervention: 1565-nm NAFL combined with topical β-glucan (B + NAFL)
Number of subjects: 64
Study 35570397 — intervention group
Group type: EXPERIMENTAL
Intervention: 1565-nm NAFL combined with topical vehicle (NAFL)
Number of subjects: 64
Study 35570397 — intervention group
Group type: COMPARATOR
Intervention: topical vehicle (Veh)
Number of subjects: 64
Study 34710538 — intervention group
Group type: EXPERIMENTAL
Intervention: High-definition transcranial direct current stimulation (HD-tDCS) at 2 mA for 20 minutes
Number of subjects: 35
Study 34710538 — intervention group
Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 35
Study 34710538 — intervention group
Group type: EXPERIMENTAL
Intervention: High-definition transcranial direct current stimulation (HD-tDCS)
Number of subjects: 35
Study 32266494 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance training (EN, n=10)
Number of subjects: 35
Study 32266494 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent training (CON, n=13)
Number of subjects: 35
Study 32266494 — intervention group
Group type: COMPARATOR
Intervention: Control group (C, n=12)
Number of subjects: 35
Study 33611623 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 17160
Study 33611623 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17160
Study 32236370 — intervention group
Group type: EXPERIMENTAL
Intervention: Team-based learning
Number of subjects: 25
Study 32236370 — intervention group
Group type: COMPARATOR
Intervention: Lecture classes
Number of subjects: 25
Study 34319948 — intervention group
Group type: EXPERIMENTAL
Intervention: Video tool for informed consent
Number of subjects: 91
Study 34319948 — intervention group
Group type: COMPARATOR
Intervention: Traditional consent
Number of subjects: 91
Study 34481471 — intervention group
Group type: EXPERIMENTAL
Intervention: Hindi version of the London Measure of Unplanned Pregnancy (LMUP)
Number of subjects: 4991
Study 33866003 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravaginal Motion‐Based Digital Health System (PDHS) for Pelvic Floor Muscle Training (PFMT)
Number of subjects: 350
Study 33866003 — intervention group
Group type: COMPARATOR
Intervention: Home Kegel exercise program (Control)
Number of subjects: 350
Study 32538776 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus acidophilus (2 strains, 5 x 10^9 cfu/capsule)
Number of subjects: 80
Study 32538776 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 35455507 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage with oil (isio4 10 mL/kg/day)
Number of subjects: 36
Study 35455507 — intervention group
Group type: COMPARATOR
Intervention: No oil massage
Number of subjects: 36
Study 32391156 — intervention group
Group type: COMPARATOR
Intervention: 23.4% NaCl
Number of subjects: 59
Study 32391156 — intervention group
Group type: EXPERIMENTAL
Intervention: 16.4% NaCl/Na-acetate
Number of subjects: 59
Study 35758895 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenosine A2A receptor antagonist
Number of subjects: 236
Study 35758895 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 236
Study 34937681 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) treatment
Number of subjects: 73
Study 34606578 — intervention group
Group type: EXPERIMENTAL
Intervention: Convalescent plasma (2 units, total volume of 550 mL)
Number of subjects: 2011
Study 34606578 — intervention group
Group type: COMPARATOR
Intervention: No convalescent plasma
Number of subjects: 2011
Study 34606578 — intervention group
Group type: EXPERIMENTAL
Intervention: Convalescent plasma
Number of subjects: 2011
Study 36224523 — intervention group
Group type: EXPERIMENTAL
Intervention: Body-focused social media posts
Number of subjects: 132
Study 36224523 — intervention group
Group type: COMPARATOR
Intervention: Control set of infant feeding tips
Number of subjects: 132
Study 33609277 — intervention group
Group type: EXPERIMENTAL
Intervention: Sarcopenic resistance training (RT)
Number of subjects: 107
Study 33609277 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-sarcopenic resistance training (RT)
Number of subjects: 107
Study 33609277 — intervention group
Group type: COMPARATOR
Intervention: Sarcopenic control
Number of subjects: 107
Study 33609277 — intervention group
Group type: COMPARATOR
Intervention: Non-sarcopenic control
Number of subjects: 107
Study 32442205 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS
Number of subjects: 71
Study 32442205 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 71
Study 36422222 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized hemodynamic management based on continuously non‐invasively measured blood pressure, heart rate, cardiac output, systemic vascular resistance, and stroke volume variation.
Number of subjects: 50
Study 36422222 — intervention group
Group type: COMPARATOR
Intervention: Conventional hemodynamic monitoring with intermittent non‐invasive blood pressure measurements.
Number of subjects: 50
Study 34507573 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical treatment (n=382)
Number of subjects: 971
Study 34507573 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment (Roux-en-Y gastric bypass, n=388; sleeve gastrectomy, n=201)
Number of subjects: 971
Study 35864562 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (DEX)
Number of subjects: 100
Study 35864562 — intervention group
Group type: COMPARATOR
Intervention: Control (traditional anesthesia)
Number of subjects: 100
Study 33530156 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive neuromuscular stabilization exercise on unstable surface
Number of subjects: 46
Study 33530156 — intervention group
Group type: COMPARATOR
Intervention: Intensive progressive exercise on stable surface
Number of subjects: 46
Study 32380460 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdisciplinary intervention (2 visits with a geriatrician)
Number of subjects: 62
Study 32380460 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 62
Study 35452273 — intervention group
Group type: EXPERIMENTAL
Intervention: Durvalumab plus oleclumab
Number of subjects: 189
Study 35452273 — intervention group
Group type: EXPERIMENTAL
Intervention: Durvalumab plus monalizumab
Number of subjects: 189
Study 35452273 — intervention group
Group type: COMPARATOR
Intervention: Durvalumab
Number of subjects: 189
Study 33295083 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled PDE4i CHF6001 (tanimilast)
Number of subjects: 41
Study 33295083 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study 36447137 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 ml of 0.375% ropivacaine
Number of subjects: 30
Study 36447137 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 ml of 0.375% ropivacaine
Number of subjects: 30
Study 36447137 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 ml of 0.375% ropivacaine
Number of subjects: 30
Study 34829373 — intervention group
Group type: EXPERIMENTAL
Intervention: Acoustic stimulation (group A)
Number of subjects: 210
Study 34829373 — intervention group
Group type: COMPARATOR
Intervention: No stimulation (group B)
Number of subjects: 210
Study 32092310 — intervention group
Group type: EXPERIMENTAL
Intervention: IW-3718 1500 mg
Number of subjects: 280
Study 32092310 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 280
Study 32092310 — intervention group
Group type: EXPERIMENTAL
Intervention: IW-3718 500 mg
Number of subjects: 280
Study 32092310 — intervention group
Group type: EXPERIMENTAL
Intervention: IW-3718 1000 mg
Number of subjects: 280
Study 32092310 — intervention group
Group type: EXPERIMENTAL
Intervention: IW-3718
Number of subjects: 280
Study 36300974 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA group (60 mg of DHA per kilogram of body weight per day)
Number of subjects: 480
Study 36300974 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 480
Study 34954967 — intervention group
Group type: EXPERIMENTAL
Intervention: 0-14 day immunization schedule
Number of subjects: 405
Study 34954967 — intervention group
Group type: EXPERIMENTAL
Intervention: 0-21 day immunization schedule
Number of subjects: 405
Study 34954967 — intervention group
Group type: EXPERIMENTAL
Intervention: 0-28 day immunization schedule
Number of subjects: 405
Study 35972259 — intervention group
Group type: EXPERIMENTAL
Intervention: MiniMed 780G advanced hybrid closed-loop (AHCL) system
Number of subjects: 41
Study 33346335 — intervention group
Group type: EXPERIMENTAL
Intervention: Dolutegravir (50 mg/d)
Number of subjects: 28
Study 33346335 — intervention group
Group type: COMPARATOR
Intervention: Efavirenz-based therapy
Number of subjects: 28
Study 34010611 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound renal denervation
Number of subjects: 989
Study 34010611 — intervention group
Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 989
Study 35902939 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium via Respimat® with spacer (AeroChamber®)
Number of subjects: 96
Study 35902939 — intervention group
Group type: COMPARATOR
Intervention: Tiotropium via Respimat® without spacer
Number of subjects: 96
Study 35902939 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium via Respimat® with spacer
Number of subjects: 96
Study 35077334 — intervention group
Group type: EXPERIMENTAL
Intervention: Stroop task (30 min)
Number of subjects: 36
Study 35077334 — intervention group
Group type: COMPARATOR
Intervention: Control task (15 min)
Number of subjects: 36
Study 35997319 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 15201
Study 35997319 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15201
Study 32333636 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial toxicity sources including travel to and from the hospital and reduced working hours during treatment
Number of subjects: 56
Study 32333636 — intervention group
Group type: EXPERIMENTAL
Intervention: Workplace flexibility
Number of subjects: 56
Study 32333636 — intervention group
Group type: EXPERIMENTAL
Intervention: Low socioeconomic areas
Number of subjects: 56
Study 32333636 — intervention group
Group type: EXPERIMENTAL
Intervention: Mothers on maternity leave during diagnosis
Number of subjects: 56
Study 35936068 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (10 μg/kg/min)
Number of subjects: 90
Study 35936068 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.5 μg/kg/h)
Number of subjects: 90
Study 35936068 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (Control)
Number of subjects: 90
Study 32918779 — intervention group
Group type: EXPERIMENTAL
Intervention: Mendelian randomization analysis
Number of subjects: 0
Study 32918779 — intervention group
Group type: EXPERIMENTAL
Intervention: Cox proportional hazard model and additive hazard model
Number of subjects: 0
Study 32224318 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton therapy
Number of subjects: 165
Study 32224318 — intervention group
Group type: COMPARATOR
Intervention: Photon therapy
Number of subjects: 165
Study 32224318 — intervention group
Group type: EXPERIMENTAL
Intervention: NTCP model-based approach
Number of subjects: 165
Study 32224318 — intervention group
Group type: EXPERIMENTAL
Intervention: Model-based trial approach
Number of subjects: 165
Study 34744066 — intervention group
Group type: EXPERIMENTAL
Intervention: WeChat-based individualized rehabilitation program (10 weeks)
Number of subjects: 72
Study 34744066 — intervention group
Group type: COMPARATOR
Intervention: Routine follow-up guidance
Number of subjects: 72
Study 33333508 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine physical therapy with VR and MI techniques, 60-min sessions, every alternate day for 12 weeks
Number of subjects: 34
Study 33333508 — intervention group
Group type: COMPARATOR
Intervention: Routine physical therapy, 40-min sessions, 20 min of walking and cycling, every alternate day for 12 weeks
Number of subjects: 34
Study 32694748 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth-based physical activity counseling intervention (adapted from the 16-session Diabetes Prevention Program)
Number of subjects: 15
Study 32694748 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC) control
Number of subjects: 15
Study 33228625 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine Replacement Therapy (NRT) package offered to half of the smokers interested in receiving it.
Number of subjects: 0
Study 33228625 — intervention group
Group type: COMPARATOR
Intervention: No nicotine patches offered to the other half of smokers.
Number of subjects: 0
Study 35389359 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist-led web-based medication adherence tool with patient-centered communication
Number of subjects: 492
Study 35389359 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 492
Study 35222585 — intervention group
Group type: EXPERIMENTAL
Intervention: Life style intervention (group A, n=40)
Number of subjects: 80
Study 35222585 — intervention group
Group type: COMPARATOR
Intervention: Control group (group B, n=40)
Number of subjects: 80
Study 35763327 — intervention group
Group type: EXPERIMENTAL
Intervention: Bionic Pancreas (BP) with insulin aspart or insulin lispro, N=112
Number of subjects: 165
Study 35763327 — intervention group
Group type: EXPERIMENTAL
Intervention: Bionic Pancreas (BP) for participants with baseline HbA1c ≥9.0% (N=34)
Number of subjects: 165
Study 35763327 — intervention group
Group type: EXPERIMENTAL
Intervention: Bionic Pancreas (BP)
Number of subjects: 165
Study 35763327 — intervention group
Group type: COMPARATOR
Intervention: Standard Care (SC), N=53
Number of subjects: 165
Study 35763327 — intervention group
Group type: COMPARATOR
Intervention: Standard Care (SC)
Number of subjects: 165
Study 32035035 — intervention group
Group type: EXPERIMENTAL
Intervention: Group Support Psychotherapy (GSP)
Number of subjects: 1140
Study 32035035 — intervention group
Group type: COMPARATOR
Intervention: Group HIV Education (GHE)
Number of subjects: 1140
Study 35661358 — intervention group
Group type: EXPERIMENTAL
Intervention: 90% bovine-derived xenograft granules in a 10% porcine collagen matrix (Group A)
Number of subjects: 54
Study 35661358 — intervention group
Group type: EXPERIMENTAL
Intervention: 80% microparticulate hydroxyapatite alloplast graft with 20% sugar cross-linked porcine type 1 collagen (Group B)
Number of subjects: 54
Study 35661358 — intervention group
Group type: COMPARATOR
Intervention: Both groups (A and B)
Number of subjects: 54
Study 35837133 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible bronchoscope
Number of subjects: 48
Study 35837133 — intervention group
Group type: COMPARATOR
Intervention: Video laryngoscope
Number of subjects: 48
Study 32037283 — intervention group
Group type: EXPERIMENTAL
Intervention: Prazosin
Number of subjects: 34
Study 32037283 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 35857546 — intervention group
Group type: EXPERIMENTAL
Intervention: Women’s Help Desks (WHDs) in police stations, staffed by trained officers.
Number of subjects: 23400000
Study 35857546 — intervention group
Group type: COMPARATOR
Intervention: Control group (police stations without WHDs)
Number of subjects: 23400000
Study 34758970 — intervention group
Group type: EXPERIMENTAL
Intervention: Information intervention for group A (n=246) that explicitly discussed misinformation and provided scientifically correct information.
Number of subjects: 736
Study 34758970 — intervention group
Group type: EXPERIMENTAL
Intervention: Information intervention for group B (n=245) that only provided correct information without discussing misinformation.
Number of subjects: 736
Study 34758970 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=245) who received two episodes about breastfeeding.
Number of subjects: 736
Study 34758970 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions (A and B).
Number of subjects: 736
Study 35980872 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal massage
Number of subjects: 63
Study 35980872 — intervention group
Group type: EXPERIMENTAL
Intervention: Stretching exercise
Number of subjects: 63
Study 35980872 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 63
Study 33516859 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation (tDCS) applied to the left M1.
Number of subjects: 18
Study 33516859 — intervention group
Group type: COMPARATOR
Intervention: Single-pulse transcranial magnetic stimulation (TMS) targeting the left primary motor cortex (M1).
Number of subjects: 18
Study 35051142 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylene Blue (MB) group
Number of subjects: 120
Study 34488646 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol TCI with Narcotrend monitor during the day (Group ND)
Number of subjects: 60
Study 34488646 — intervention group
Group type: COMPARATOR
Intervention: Propofol TCI with Narcotrend monitor during the night (Group NN)
Number of subjects: 60
Study 34488646 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol closed-loop TCI guided by BIS during the day (Group CLTD)
Number of subjects: 60
Study 34488646 — intervention group
Group type: COMPARATOR
Intervention: Propofol closed-loop TCI guided by BIS during the night (Group CLTN)
Number of subjects: 60
Study 34362344 — intervention group
Group type: EXPERIMENTAL
Intervention: NACT + SBRT + durvalumab + oleclumab
Number of subjects: 136
Study 34362344 — intervention group
Group type: EXPERIMENTAL
Intervention: NACT + SBRT + durvalumab
Number of subjects: 136
Study 34362344 — intervention group
Group type: EXPERIMENTAL
Intervention: NACT + SBRT + oleclumab
Number of subjects: 136
Study 34362344 — intervention group
Group type: EXPERIMENTAL
Intervention: NACT + SBRT
Number of subjects: 136
Study 32271710 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical silicone-based scar cream containing selective synthetic recombinant human growth factors, hyaluronic acid, and vitamin C applied twice a day for 1 month.
Number of subjects: 22
Study 32271710 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical silicone-based scar cream (treated group)
Number of subjects: 22
Study 32271710 — intervention group
Group type: COMPARATOR
Intervention: Untreated SD (control group)
Number of subjects: 22
Study 35468093 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized Nutrition (PN) advice via the eNutri web app
Number of subjects: 210
Study 35468093 — intervention group
Group type: COMPARATOR
Intervention: Control advice (population-based healthy eating guidelines)
Number of subjects: 210
Study 33706428 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepwise pain management (oral acetaminophen 10-15 mg/kg every 4-6 hours for moderate pain, morphine 0.1-0.2 mg/kg every 4 hours for severe pain)
Number of subjects: 196
Study 33706428 — intervention group
Group type: COMPARATOR
Intervention: Traditional pain management
Number of subjects: 196
Study 33706428 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepwise pain management
Number of subjects: 196
Study 36098301 — intervention group
Group type: EXPERIMENTAL
Intervention: Journeying through Dementia (JtD) intervention plus standard care
Number of subjects: 480
Study 36098301 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 480
Study 36098301 — intervention group
Group type: EXPERIMENTAL
Intervention: Journeying through Dementia (JtD) intervention
Number of subjects: 480
Study 34144603 — intervention group
Group type: EXPERIMENTAL
Intervention: MTX-PGs quartiles (specifically MTX-PGs 3-5)
Number of subjects: 2391
Study 34144603 — intervention group
Group type: EXPERIMENTAL
Intervention: MTX-PGs levels >134 nmol/l
Number of subjects: 2391
Study 32651163 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 34556722 — intervention group
Group type: EXPERIMENTAL
Intervention: Normobaric oxygen treatment (35% fraction of inspired oxygen)
Number of subjects: 55
Study 34556722 — intervention group
Group type: COMPARATOR
Intervention: Room air (21% fraction of inspired oxygen)
Number of subjects: 55
Study 34667023 — intervention group
Group type: EXPERIMENTAL
Intervention: Epirubicin/cyclophosphamide followed by nivolumab, triptorelin, and exemestane
Number of subjects: 43
Study 34667023 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab
Number of subjects: 43
Study 32539150 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual telephone counseling
Number of subjects: 445
Study 32539150 — intervention group
Group type: EXPERIMENTAL
Intervention: Group telephone counseling
Number of subjects: 445
Study 32539150 — intervention group
Group type: COMPARATOR
Intervention: Email education control
Number of subjects: 445
Study 35115250 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes health coaching intervention
Number of subjects: 0
Study 35115250 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 0
Study 33103770 — intervention group
Group type: EXPERIMENTAL
Intervention: CCB + statin group
Number of subjects: 189
Study 33103770 — intervention group
Group type: EXPERIMENTAL
Intervention: valsartan group
Number of subjects: 189
Study 33103770 — intervention group
Group type: EXPERIMENTAL
Intervention: valsartan + statin group
Number of subjects: 189
Study 33103770 — intervention group
Group type: COMPARATOR
Intervention: CCB group
Number of subjects: 189
Study 34894205 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereoscopic 3D view
Number of subjects: 66
Study 34894205 — intervention group
Group type: COMPARATOR
Intervention: Monoscopic 3D view
Number of subjects: 66
Study 34247727 — intervention group
Group type: EXPERIMENTAL
Intervention: Job applicants with 'foreign' names in high-skilled positions
Number of subjects: 6407
Study 34247727 — intervention group
Group type: EXPERIMENTAL
Intervention: Job applicants with 'foreign' names in low-skilled positions
Number of subjects: 6407
Study 34247727 — intervention group
Group type: EXPERIMENTAL
Intervention: Male job applicants with 'foreign' names
Number of subjects: 6407
Study 32353623 — intervention group
Group type: EXPERIMENTAL
Intervention: Labral size in the upper decile of the cohort
Number of subjects: 571
Study 32353623 — intervention group
Group type: COMPARATOR
Intervention: Labral width
Number of subjects: 571